Jagsonpal Pharmaceuticals share news, announcements and annual reports
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Jagsonpal Pharmaceuticals Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1987 on BSE, Mar 2000 on NSE
Last close ₹216.09down ₹5.85 (2.64%)BSE ₹216.90
Share price at the NSE close on 30 Oct 2026. Previous close ₹221.94.
30 Oct: open ₹222.00, high ₹226.64, low ₹212.58
52-week range of traded prices to 30 Oct 2026
₹155.00Low, 22 Jan 2026₹264.50High, 30 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,427 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 5.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.85%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 71,54749.3% delivered
Jagsonpal Pharmaceuticals share news and announcements
550 announcements, routine notices left out, newest first. Page 11 of 11.
Jun 2012
1 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2012 has recommended a dividend of Rs. 0.50 per equity shares on 2,61,98,000 Equity Shares of Rs. 5/ each for the year 2011-12.
May 2012
30 May · Results
21 May · Board meeting
To : (1) Consider and Approve the Audited Financial Results for the quarter/ year ended March 31, 2012; (2) Recommend dividend, if any, for the year ended March 31, 2012.
Feb 2012
3 Feb · Board meeting
To consider and take on record the un-audited financial results (provisional) for Quarter ended on December 31, 2011.
Nov 2011
8 Nov · Board meeting
To consider and take on record the un-audited financial results (provisional) for Quarter ended on September 30, 2011.
Oct 2011
Sep 2011
13 Sep · Meeting
Annual General Meeting of the Company will be held on September 30, 2011.7 Sep · Corporate action
Company has announced the Book Closure from September 27, 2011 to September 30, 2011 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2011 and for the purpose of Annual General Meeting.
Aug 2011
16 Aug · Results
1 Aug · Board meeting
To : (1) Consider and Approve the Audited financial results for the quarter/year ended March 31, 2011; (2) Recommend dividend, if any, for the year ended March 31, 2011; (3) Consider and take on record the Un-Audited financial results (Provisional) for the quarter ended June 30, 2011.
May 2011
13 May · Results
4 May · Board meeting
To consider and take on record the un-audited financial results (provisional) for Quarter/ Year ended on March 31, 2011.
Feb 2011
1 Feb · Board meeting
To consider and take on record the un-audited financial results (provisional) for Quarter/ period ended on December 31, 2010.
Nov 2010
8 Nov · Board meeting
To consider and take on record the un-audited financial results (provisional) for Quarter/ year ended on September 30, 2010.
Sep 2010
7 Sep · Corporate action
Register of Members and Share Transfer Books shall remain closed from September 23, 2010 to September 25, 2010 (both days inclusive) for the purpose of dividend of Rs. 0.50 only (Paisa Fifty only) per equity share of Rs. 5/- each for the Financial Year ended March 31, 2010 and for the purpose of Annual General Meeting.
Aug 2010
3 Aug · Board meeting
(1) Consider and Approve the Audited financial results for the quarter/year ended March 31, 2010. (2) Recommend dividend, if any, for the year ended March 31, 2010. (3) Consider and take on record the Un-audited financial results (Provisional) for the quarter ended June 30, 2010.
May 2010
5 May · Board meeting
To consider and take on record the un-audited financial results (provisional) for Quarter/ year ended March 31, 2010.
Jan 2010
20 Jan · Board meeting
To consider and take on record the un-audited financial results (provisional) for the quarter ended December 31, 2009.
Oct 2009
20 Oct · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter ended on September 30, 2009.1 Oct · Meeting
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Shareholders/members of the company at their Annual General Meeting held on September 30, 2009 have : 1) Adopted the Audited Balance Sheet as at March 31, 2009 and the Profit and loss account for the year ended on that date alongwith the reports of the Auditors and Directors thereon. 2) Declared 5% dividend on the Equity Shares. 3) Re-appointed Mr. A. C. Chakrabortti as Director whose period of office is liable to determination by retirement of Directors by rotation. 4) Appointed P.P. Thukral & Company, Chartered Accountants as Auditor to hold office till the conclusion of next Annual General Meeting.
Sep 2009
18 Sep · Meeting
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 30, 2009.7 Sep · Corporate action
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Company has announced the Book Closure from September 25, 2009 to September 30, 2009 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.25 only (Paisa Twenty Five only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2009 and for the purpose of Annual General Meeting.
Jul 2009
18 Jul · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter ended on June 30, 2009.
Jun 2009
30 Jun · Dividend
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors in their Meeting held on June 30, 2009 has, recommended dividend of Rs.0.25 (Paise Twenty-five only) per equity share of Rs.5/- each for the year ended March 31, 2009.15 Jun · Board meeting
1) To consider and approve the Audited financial results for the quarter / year ended March 31, 2009. 2) Recommend dividend, if any, for the year ended March 31, 2009.
Apr 2009
22 Apr · Results
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that "The Company will be publishing the Audited results for the accounting year 2008-2009 within a period of 3 months of the close of the accounting year".8 Apr · Commencement of commercial production
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that: "Commercial production at our new manufacturing facility at Integrated Industrial Estate, Pant Nagar, District Udham Singh Nagar, Uttarakhand has commenced on 8th April 2009. The Company shall be producing selected drugs and pharmaceuticals products at the above manufacturing facility".
Jan 2009
16 Jan · Board meeting
Meeting on 28 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
20 Oct · Board meeting
Meeting on 31 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”6 Oct · Meeting
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the shareholders/members of the company at their Annual General Meeting held on September 29, 2008 have : 1) Adopted the Audited Balance Sheet as at March 31, 2008 and the Profit and Loss account for the year ended on that date alongwith the reports of the Auditors' and Directors' thereon. 2) Declared 2% dividend on the Equity Shares. 3) Re-appointed Dr. S. K. Goyal as Director whose period of office is liable to determination by retirement of Directors by rotation. 4) Appointed P. P. Thukral & Company, Chartered Accountants as Auditor to hold office till the conclusion of next Annual General Meeting. 5) Approved special resolution for increase in remuneration of Chairman. 6) Approved special resolution for increase in remuneration of Managing Director.
Sep 2008
16 Sep · Meeting
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 29, 2008.1 Sep · Corporate action
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Book Closure is from September 26, 2008 to September 29, 2008 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.10 only (Paisa 10 only) per Equity Shares of Rs 5/- each for the Financial Year March 31, 2008 and for the purpose of Annual General Meeting.
Aug 2008
21 Aug · Board meeting
(1) To consider and approve the Audited financial results for the quarter/year ended March 31, 2008.(2) Recommend dividend, if any, for the year ended March 31, 2008.
Jul 2008
17 Jul · Board meeting
To consider and take on record the unaudited financial results (provisional) for quarter ended on June 30, 2008.
Apr 2008
16 Apr · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter/ Year ended on 31.03.2008.
Jan 2008
22 Jan · Board meeting
Meeting on 31 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
19 Oct · Board meeting
Meeting on 30 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Sep 2007
18 Sep · Meeting
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on September 29, 2007.
Aug 2007
29 Aug · Corporate action
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Company has announced book closure from September 25, 2007 to September 29, 2007 (both days inclusive) for the purpose of dividend of Rs. 0.10 only (Paisa Ten Only) Per Equity Share of Rs. 5/- each for the financial year ended March 31, 2007 and for the purpose of Annual General Meeting.27 Aug · Dividend
Jagsonpal Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on August 25, 2007 has recommended dividend of Rs. 0.10 (Paise Ten Only) on 2,61,98,000 Equity shares of Rs. 5/- each for the financial year ended March 31, 2007.16 Aug · Board meeting
To (1) Consider and approve the audited financial results for Quarter/year ended on March 31, 2007 and (2) Recommend Dividend, if any, for the year ended March 31, 2007.
Jul 2007
17 Jul · Board meeting
Meeting on 28 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Apr 2007
21 Apr · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter ended on 31.03.2007.
Jan 2007
23 Jan · Board meeting
A meeting of the Board of Direcotrs of the Company is now scheduled to be held on 30th January, 2007 to consider and take on record the unaudited financial results (provisional) for Quarter ended on 31.12.2006. Our earlier notice dated 17.1.2007 (informing date of Board Meeting as 29th January, 2007) may please be treated as cancelled17 Jan · Board meeting
Meeting on 29 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”